Loading
Life sciences · Journal article
Acs Applied Bio Materials · October 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Treatment of cancer is often hindered by drug resistance and severe side effects associated with conventional chemotherapy. To address these limitations, multimodal therapeutic strategies, such as chemo-photodynamic therapy combining chemotherapy and photodynamic therapy, have emerged as a promising alternative. In this study, we report the design, synthesis, and evaluation of BODIPY–N-heterocyclic carbene (NHC)–silver complexes as chemophototheranostic agents for synergistic cancer treatment. A series of four BODIPY–NHC–silver complexes were synthesized and fully characterized using different spectroscopic techniques. These complexes integrate the imaging capability of BODIPY dyes with the chemotherapeutic potential of silver, while also acting as efficient photosensitizers for the generation of reactive oxygen species (ROS) upon light irradiation. Biological investigations revealed significant anticancer activity under dark conditions, confirming the chemotherapeutic activity of the silver complexes. Among the four BODIPY–NHC–silver complexes, di-iodo-di-styryl-BODIPY-NHC-silver complex 15 showed enhanced cytotoxicity to cancer cells upon photoactivation, confirming synergistic chemo-photodynamic therapeutic effects. Mechanistic studies indicated mitochondrial localization and ROS-mediated mitochondrial network disruption due to the chemo-photodynamic therapeutic effect successfully activating the apoptotic pathway, leading to efficient cancer cell death. Overall, this work highlights the potential of BODIPY–NHC–silver complexes as synthetically accessible and effective platforms for multimodal cancer therapy.